WEST PHARMACEUTICAL SVSC INC (WST) — Hedge Fund Ownership Q4 2025
WST
- WEST PHARMACEUTICAL SVSC INC (WST) is held by 3 of 82 tracked hedge funds, with Hillman Capital Management (2%) and Gates Foundation Trust (0.3%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in WST holdings came from Hillman Capital Management (-13%), suggesting profit-taking or de-risking.
- 1 hedge fund exited WST, led by Durable Capital Partners (2%).
- Overall, hedge funds decreased exposure to WEST PHARMACEUTICAL SVSC INC (WST) by -72% vs the prior quarter and -100% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Hillman Capital Management Mark Hillman
|
1.54% | 9K | -13.31% | — | $2.5M | $275.14 | — |
| 2 |
Gates Foundation Trust
|
0.35% | 444K | — | — | $122.3M | $275.14 | — |
| 3 |
Viking Global Investors Andreas Halvorsen
|
0.22% | 295K | NEW | — | $81.2M | $275.14 | — |
| — |
Durable Capital Partners Henry Ellenbogen
|
— | — | EXITED | — | — | — | — |
| 3 | Total | — | 748K | -72.14% | -100.00% | $205.9M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.